report strong quarterli result increas guidanc impress
strong growth deriv invest technolog platform make
compani begin look like tech compani cro remain neutral
valuat look continu momentum technolog share gain drive
multipl expans rais pt reflect increas ebitda
estim ebitda w/ net debt
invest deliv growth invest past month
technolog stack next gener clinic develop real-world data deliv
promis deal flow quarter sign second notabl win
top five pharma client leverag new single-arm studi capabl formul
retrospect synthet control arm use rwe data intrigu use case
rwe data manag indic fda becom recept
approach also compani launch new version orchestr custom
engag oce offer onto platform drive demand
well deliv notabl win quarter includ top former client adopt
platform global
 solut deliv book revenu ltm contract net new busi
grew y/i book/bil greater win busi client
histor relationship legaci quintil new
busi award nextgen clinic develop offer amount
total nextgen busi sinc time merger report growth
segment point growth driven acquisit also
segment report higher normal level pass revenu help fuel
top line strength
number revenu beat pjc consensu three sourc
upsid strong organ growth solut busi unit higher
pass-through solut revenu inorgan contribut ep beat
pjc consensu ebitda pjc beat
consensu compani rais guidanc also provid guidanc
exceed expect exhibit
chang pharma industri impact spend drug research revers
current increas outsourc trend pharma industri averag leverag
balanc sheet impact opportun
iqvia largest cro industri expertis across major therapeut
oper countri
price close juli
ebitda
net debt s/o
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
sale
compani document piper jaffray co
compani document piper jaffray co
page
revenu
revenu reimburs expens
consolid incom oper
loss extinguish debt
sale busi
incom tax
tax incom
equiti earn unconsolid affili
loss incom non-control interest
revenu
current disclosur inform compani locat
